BRONCHODILATING ACTIVITY OF A NEW BETA-2-AGONIST - BROXATEROL HYDROCHLORIDE BY INHALATION

被引：0
|
作者：
CASALI, L [1 ]
ROSSI, A [1 ]
MANAZZA, P [1 ]
COLOMBO, ML [1 ]
ZOIA, MC [1 ]
机构：
[1] UNIV PAVIA,POLICLIN SAN MATTEO,DIV PNEUMOL,I-27100 PAVIA,ITALY
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1986年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：823 / 829
页数：7
相关论文
共 50 条
  • [1] PREVENTION OF ALLERGEN-INDUCED BRONCHOSPASM BY A NEW BETA-2-AGONIST BROXATEROL HYDROCHLORIDE - DOUBLE-BLIND CROSSOVER STUDY
    BALZANO, G
    SCHIANO, M
    GURRIERI, G
    MELILLO, G
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S139 - S139
  • [2] PREVENTION OF ALLERGEN-INDUCED BRONCHOSPASM BY A NEW BETA-2-AGONIST BROXATEROL HYDROCHLORIDE - DOUBLE-BLIND CROSSOVER STUDY
    BALZANO, G
    SCHIANO, M
    GURRIERI, G
    MELILLO, G
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S170 - S170
  • [3] BRONCHODILATOR ACTIVITY OF A NEW BETA-2-AGONIST - 1-(3-BROMO-5-ISOXAZOLYL)-2-(TERT-BUTYLAMINO) ETHANOL HYDROCHLORIDE (BROXATEROL HYDROCHLORIDE)
    ROBUSCHI, M
    SIMONE, P
    VAGHI, A
    FASANO, W
    BIANCO, S
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1986, 69 : A139 - A139
  • [4] BROXATEROL (Z.1170), A NEW ORAL BETA-2-AGONIST COMPARED WITH SALBUTAMOL
    PERRUCHOUD, AP
    BRUNDLER, H
    GODLY, R
    IMHOF, E
    HERZOG, H
    RESPIRATION, 1987, 51 (02) : 113 - 118
  • [5] EVALUATION OF THE BRONCHODILATING ACTIVITY AND THE TOLERABILITY OF BROXATEROL ADMINISTERED AS A SOLUTION BY INHALATION
    FERRARI, M
    OLIVIERI, M
    BIASIN, C
    PISATI, R
    LODOLA, E
    LOCASCIO, V
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-1 (05): : 553 - 558
  • [6] EARLY BRONCHODILATING EFFECT OF A NEW ORAL BETA-2-RECEPTOR AGONIST (BROXATEROL) IN BRONCHIAL-ASTHMA
    CHETTA, A
    GARAVALDI, G
    CUOMO, A
    GURRIERI, G
    OLIVIERI, D
    RESPIRATION, 1988, 53 (04) : 220 - 224
  • [7] NEGLIGIBLE METABOLIC EFFECTS OF LONG-TERM ORAL TREATMENT WITH A NEW BETA-2-AGONIST - BROXATEROL
    PETRAGLIA, A
    SCARPITTA, M
    ANSALONE, D
    GURRIERI, G
    GALZERANO, V
    CALVANESE, RC
    FEDERICO, S
    ZINNO, A
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1990, 10 (05) : 299 - 304
  • [8] CLINICAL-EVALUATION OF THE BRONCHODILATOR ACTIVITY OF A NEW BETA-2-AGONIST - 1-(3-BROMO-5-ISOXAZOLYL)-2-(TERT-BUTYLAMINO) ETHANOL HYDROCHLORIDE (BROXATEROL HYDROCHLORIDE)
    CASALI, L
    ROSSI, A
    MANAZZA, P
    COLOMBO, ML
    ZOIA, MC
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1986, 69 : A33 - A33
  • [9] COMPARISON OF A NEW SELECTIVE BETA-2-AGONIST, BROXATEROL, AND SALBUTAMOL ORALLY-ADMINISTERED FOR 7-DAY PERIODS
    BORGIA, M
    SIMONE, P
    BORGIA, R
    VENTRESCA, GP
    LODOLA, E
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1986, 69 : A22 - A22
  • [10] MODIFICATIONS OF MANUAL TREMBLING CONSECUTIVE TO INHALATION OF BETA-2-AGONIST AEROSOLS
    DELHEZ, L
    LINDEN, P
    LOVERIUS, JP
    PAULIS, M
    PETIT, JM
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1984, 92 (04): : P38 - P39
12345